This article is more than 5 years old. Information may no longer be current.

Tornier names new president, CEO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The board of directors of Tornier has appointed David H. Mowry as president and chief executive officer.

Before Mowry joined Tornier in July 2011 as chief operating officer, he served as senior vice president and president of the neurovascular division of Covidien plc, according to a company press release. He also served in the same positions prior to Covidien with ev3 Inc., and as vice president of operations and logistics at the Zimmer Spine division of Zimmer Holdings Inc. “Tornier’s industry expertise, broad product portfolio, and cadence of delivering innovation position the company as a recognized global leader in the large and growing extremities markets. We believe the increased focus on execution of our U.S. sales channel alignment, OrthoHelix integration, and delivering through our strong product pipeline will return Tornier to double-digit, constant currency revenue growth on a pro forma basis,” Mowry stated in the release.